|
⚲
|
| Keyboard |
| Holdbrook Mark J
✚
|
|
|---|---|
| CIK # | 0001827564 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001827564] | |
| 4 | [0001827564] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Holdbrook Mark J | |
| Tarsus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2023-03-20 | Sell | 198 | $12.61 | 2,497 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2023-03-17 | Sell | 188 | $13.28 | 2,497 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2023-03-16 | Sell | 187 | $13.43 | 2,511 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2023-03-15 | Option exercise | 2,653 | ||
|
Tarsus Pharmaceuticals Inc TARS
Restricted Stock Units · derivative
|
2023-03-15 | Option exercise | 2,653 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Restricted Stock Units · derivative
|
2022-03-09 | Grant | 10,612 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Stock Option (right to buy) · derivative
|
2022-03-09 | Grant | 36,173 | $0.00 | |
|
Tarsus Pharmaceuticals Inc TARS
Stock Option (right to buy) · derivative
|
2021-03-02 | Grant | 14,300 | $0.00 |